{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:15:51Z","timestamp":1778667351839,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,10,20]]},"DOI":"10.1038\/onc.2016.97","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T11:07:18Z","timestamp":1459768038000},"page":"5565-5575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8"],"prefix":"10.1038","volume":"35","author":[{"given":"W","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K P","family":"Maniar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A W","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Krensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Clayberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"key":"BFonc201697_CR1","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"M Arbyn","year":"2011","unstructured":"Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22: 2675\u20132686.","journal-title":"Ann Oncol"},{"key":"BFonc201697_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12\u201319.","journal-title":"J Pathol"},{"key":"BFonc201697_CR3","doi-asserted-by":"publisher","first-page":"S3\/11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F . Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24: S3\/11\u201325.","journal-title":"Vaccine"},{"key":"BFonc201697_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367: 1247\u20131255.","journal-title":"Lancet"},{"key":"BFonc201697_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA . Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550\u2013560.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201697_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fmicb.2012.00152","volume":"3","author":"N Kajitani","year":"2012","unstructured":"Kajitani N, Satsuka A, Kawate A, Sakai H . Productive lifecycle of human papillomaviruses that depends upon squamous epithelial differentiation. Front Microbiol 2012; 3: 152.","journal-title":"Front Microbiol"},{"key":"BFonc201697_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2217\/fmb.13.127","volume":"8","author":"S Hong","year":"2013","unstructured":"Hong S, Laimins LA . Regulation of the life cycle of HPVs by differentiation and the DNA damage response. Fut Microbiol 2013; 8: 1547\u20131557.","journal-title":"Fut Microbiol"},{"key":"BFonc201697_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ . Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014; 14: 395\u2013405.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201697_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/scbi.1996.0043","volume":"7","author":"C Desaintes","year":"1996","unstructured":"Desaintes C, Demeret C . Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 1996; 7: 339\u2013347.","journal-title":"Semin Cancer Biol"},{"key":"BFonc201697_CR10","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1128\/JVI.74.11.5198-5205.2000","volume":"74","author":"W Ai","year":"2000","unstructured":"Ai W, Narahari J, Roman A . Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J Virol 2000; 74: 5198\u20135205.","journal-title":"J Virol"},{"key":"BFonc201697_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.virol.2008.11.014","volume":"384","author":"F Thierry","year":"2009","unstructured":"Thierry F . Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma. Virology 2009; 384: 375\u2013379.","journal-title":"Virology"},{"key":"BFonc201697_CR12","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1182\/blood-2010-05-285353","volume":"116","author":"Z Cao","year":"2010","unstructured":"Cao Z, Sun X, Icli B, Wara AK, Feinberg MW . Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 2010; 116: 4404\u20134414.","journal-title":"Blood"},{"key":"BFonc201697_CR13","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW . Mammalian Kruppel-like factors in health and diseases. Physiol Rev 2010; 90: 1337\u20131381.","journal-title":"Physiol Rev"},{"key":"BFonc201697_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.18632\/oncotarget.1456","volume":"5","author":"R Limame","year":"2014","unstructured":"Limame R, Op de Beeck K, Lardon F, De Wever O, Pauwels P . Kruppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget 2014; 5: 29\u201348.","journal-title":"Oncotarget"},{"key":"BFonc201697_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/MCB.01071-06","volume":"27","author":"YT Ahn","year":"2007","unstructured":"Ahn YT, Huang B, McPherson L, Clayberger C, Krensky AM . Dynamic interplay of transcriptional machinery and chromatin regulates \"late\" expression of the chemokine RANTES in T lymphocytes. Mol Cell Biol 2007; 27: 253\u2013266.","journal-title":"Mol Cell Biol"},{"key":"BFonc201697_CR16","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci D, Colombatti A . The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm 2014; 2014: 292376.","journal-title":"Mediators Inflamm"},{"key":"BFonc201697_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000308303","volume":"128","author":"BJ Henson","year":"2010","unstructured":"Henson BJ, Gollin SM . Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res 2010; 128: 192\u2013198.","journal-title":"Cytogenet Genome Res"},{"key":"BFonc201697_CR18","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood-2012-03-415968","volume":"120","author":"DS Kim","year":"2012","unstructured":"Kim DS, Zhang W, Millman SE, Hwang BJ, Kwon SJ, Clayberger C et al. Fbw7gamma-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes. Blood 2012; 120: 1658\u20131667.","journal-title":"Blood"},{"key":"BFonc201697_CR19","doi-asserted-by":"publisher","first-page":"e1000605","DOI":"10.1371\/journal.ppat.1000605","volume":"5","author":"CA Moody","year":"2009","unstructured":"Moody CA, Laimins LA . Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathogens 2009; 5: e1000605.","journal-title":"PLoS Pathogens"},{"key":"BFonc201697_CR20","doi-asserted-by":"publisher","first-page":"e1003321","DOI":"10.1371\/journal.ppat.1003321","volume":"9","author":"N Sakakibara","year":"2013","unstructured":"Sakakibara N, Chen D, McBride AA . Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells. PLoS Pathogens 2013; 9: e1003321.","journal-title":"PLoS Pathogens"},{"key":"BFonc201697_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1323879","volume":"257","author":"C Meyers","year":"1992","unstructured":"Meyers C, Frattini MG, Hudson JB, Laimins LA . Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257: 971\u2013973.","journal-title":"Science"},{"key":"BFonc201697_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/viro.1996.0530","volume":"224","author":"D Apt","year":"1996","unstructured":"Apt D, Watts RM, Suske G, Bernard HU . High Sp1\/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virol 1996; 224: 281\u2013291.","journal-title":"Virol"},{"key":"BFonc201697_CR23","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1007\/s13277-014-2380-4","volume":"35","author":"D Marrero-Rodriguez","year":"2014","unstructured":"Marrero-Rodriguez D, Taniguchi-Ponciano K, Jimenez-Vega F, Romero-Morelos P, Mendoza-Rodriguez M, Mantilla A et al. Kruppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression. Tumour Biol 2014; 35: 11399\u201311407.","journal-title":"Tumour Biol"},{"key":"BFonc201697_CR24","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.27632","volume":"62","author":"X Zhao","year":"2010","unstructured":"Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 2010; 62: 3425\u20133435.","journal-title":"Arthritis Rheum"},{"key":"BFonc201697_CR25","doi-asserted-by":"publisher","first-page":"21505","DOI":"10.1073\/pnas.1016218107","volume":"107","author":"AG Ooi","year":"2010","unstructured":"Ooi AG, Sahoo D, Adorno M, Wang Y, Weissman IL, Park CY . MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc Natl Acad Sci USA 2010; 107: 21505\u201321510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201697_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc2290","volume":"8","author":"M Welcker","year":"2008","unstructured":"Welcker M, Clurman BE . FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83\u201393.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201697_CR27","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1128\/JVI.03317-14","volume":"89","author":"E Forte","year":"2015","unstructured":"Forte E, Raja AN, Shamulailatpam P, Manzano M, Schipma MJ, Casey JL et al. MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus. J Virol 2015; 89: 2333\u20132341.","journal-title":"J Virol"},{"key":"BFonc201697_CR28","doi-asserted-by":"publisher","first-page":"e1003295","DOI":"10.1371\/journal.ppat.1003295","volume":"9","author":"S Hong","year":"2013","unstructured":"Hong S, Laimins LA . The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathogens 2013; 9: e1003295.","journal-title":"PLoS Pathogens"},{"key":"BFonc201697_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2427(02)00136-8","volume":"88","author":"A Grone","year":"2002","unstructured":"Grone A . Keratinocytes and cytokines. Vet Immunol Immunopathol 2002; 88: 1\u201312.","journal-title":"Vet Immunol Immunopathol"},{"key":"BFonc201697_CR30","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1002\/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F","volume":"92","author":"D Masuya","year":"2001","unstructured":"Masuya D, Huang C, Liu D, Kameyama K, Hayashi E, Yamauchi A et al. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 2001; 92: 2628\u20132638.","journal-title":"Cancer"},{"key":"BFonc201697_CR31","first-page":"729","volume":"9","author":"JJ Chen","year":"2003","unstructured":"Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 2003; 9: 729\u2013737.","journal-title":"Clin Cancer Res"},{"key":"BFonc201697_CR32","first-page":"2632","volume":"60","author":"J Fujimoto","year":"2000","unstructured":"Fujimoto J, Sakaguchi H, Aoki I, Tamaya T . Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60: 2632\u20132635.","journal-title":"Cancer Res"},{"key":"BFonc201697_CR33","first-page":"69","volume":"375","author":"S Wu","year":"2013","unstructured":"Wu S, Shang H, Cui L, Zhang Z, Zhang Y, Li Y et al. Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis. Mol Cell Biochem 2013; 375: 69\u201379.","journal-title":"Mol Cell Biochem"},{"key":"BFonc201697_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.virol.2010.11.010","volume":"410","author":"J Walker","year":"2011","unstructured":"Walker J, Smiley LC, Ingram D, Roman A . Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration. Virology 2011; 410: 283\u2013290.","journal-title":"Virology"},{"key":"BFonc201697_CR35","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.febslet.2014.04.027","volume":"588","author":"JC Simard","year":"2014","unstructured":"Simard JC, Noel C, Tessier PA, Girard D . Human S100A9 potentiates IL-8 production in response to GM-CSF or fMLP via activation of a different set of transcription factors in neutrophils. FEBS Lett 2014; 588: 2141\u20132146.","journal-title":"FEBS Lett"},{"key":"BFonc201697_CR36","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","volume":"117","author":"EA Nelson","year":"2011","unstructured":"Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 2011; 117: 3421\u20133429.","journal-title":"Blood"},{"key":"BFonc201697_CR37","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ccr.2012.10.023","volume":"22","author":"A Britschgi","year":"2012","unstructured":"Britschgi A, Andraos R, Brinkhaus H, Klebba I, Romanet V, Muller U et al. JAK2\/STAT5 inhibition circumvents resistance to PI3K\/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell 2012; 22: 796\u2013811.","journal-title":"Cancer Cell"},{"key":"BFonc201697_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2014","unstructured":"Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ et al. Landscape of genomic alterations in cervical carcinomas. Nature 2014; 506: 371\u2013375.","journal-title":"Nature"},{"key":"BFonc201697_CR39","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.2537532","volume":"243","author":"N Dyson","year":"1989","unstructured":"Dyson N, Howley PM, Munger K, Harlow E . The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934\u2013937.","journal-title":"Science"},{"key":"BFonc201697_CR40","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","volume":"8","author":"K Munger","year":"1989","unstructured":"Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM . Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989; 8: 4099\u20134105.","journal-title":"EMBO J"},{"key":"BFonc201697_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1517\/13543784.2012.677432","volume":"21","author":"BL Harry","year":"2012","unstructured":"Harry BL, Eckhardt SG, Jimeno A . JAK2 inhibition for the treatment of hematologic and solid malignancies. Exp Opin Invest Drugs 2012; 21: 637\u2013655.","journal-title":"Exp Opin Invest Drugs"},{"key":"BFonc201697_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","volume":"12","author":"K Xie","year":"2001","unstructured":"Xie K . Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001; 12: 375\u2013391.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc201697_CR43","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh DJ, Wilson C . The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735\u20136741.","journal-title":"Clin Cancer Res"},{"key":"BFonc201697_CR44","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-03-0760","volume":"10","author":"JE De Larco","year":"2004","unstructured":"De Larco JE, Wuertz BR, Furcht LT . The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004; 10: 4895\u20134900.","journal-title":"Clin Cancer Res"},{"key":"BFonc201697_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2249.1992.tb06990.x","volume":"89","author":"HS Anttila","year":"1992","unstructured":"Anttila HS, Reitamo S, Ceska M, Hurme M . Signal transduction pathways leading to the production of IL-8 by human monocytes are differentially regulated by dexamethasone. Clin Exp Immunol 1992; 89: 509\u2013512.","journal-title":"Clin Exp Immunol"},{"key":"BFonc201697_CR46","first-page":"317","volume":"292","author":"F Fehrmann","year":"2005","unstructured":"Fehrmann F, Laimins LA . Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol 2005; 292: 317\u2013330.","journal-title":"Methods Mol Biol"},{"key":"BFonc201697_CR47","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/onc.2010.12","volume":"29","author":"W Zhang","year":"2010","unstructured":"Zhang W, Zeng X, Briggs KJ, Beaty R, Simons B, Chiu Yen RW et al. A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene 2010; 29: 2467\u20132476.","journal-title":"Oncogene"},{"key":"BFonc201697_CR48","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ni.1656","volume":"9","author":"W Liao","year":"2008","unstructured":"Liao W, Schones DE, Oh J, Cui Y, Cui K, Roh TY et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol 2008; 9: 1288\u20131296.","journal-title":"Nat Immunol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201697","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:23:59Z","timestamp":1647894239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":48,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2016,10,20]]}},"alternative-id":["BFonc201697"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.97","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]},"assertion":[{"value":"28 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}